Si vives en EEUU o Latinomérica

compra aquí


Busca todo lo que quieras en Invertirenbolsa.info
con este buscador personalizado de Google
:

Búsqueda personalizada


Libro La Economía funcionará cuando TÚ la entiendas de Gregorio Hernández Jiménez (invertirenbolsa.info)

Si vives en EEUU o Latinomérica

compra aquí
Busca todo lo que quieras en Invertirenbolsa.info con este buscador personalizado de Google:
Búsqueda personalizada
Gracias Gracias:  3
Me gusta Me gusta:  1
Página 2 de 3 PrimeroPrimero 123 ÚltimoÚltimo
Mostrando resultados del 11 al 20 de 24

Tema: Paragon Care

  1. #11
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado


    Consulta aquí qué empresas tienen los inversores en sus carteras en las estadísticas de Invertirenbolsa.info




  2. #12
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado

    En breve publican, buen momento para entrar, está corregida y con todas las adquisiciones y desarrollo que hay en temas médicos en Australia, deben haber buen momentum, Además, per 12.



  3. #13
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado

    Paragon Care ready for SA expansion with new US partner, office facility and warehouse

    Valerina Changarathil, The Advertiser
    December 27, 2017 6:03am


    Subscriber only





    Ads by Kiosked




    VICTORIAN medical equipment supplier Paragon Care has roped in a US partner to expand it distribution footprint in SA.

    Paragon Care will be the exclusive distributor for US medical products supplier Smiths Medical and their suite of products into SA.
    Australian sharemarket-listed Paragon is currently finalising fitout and logistics for a new warehouse and office space in Wingfield, which is due to open next month.
    Managing director Mark Simari said the company was talking to “a number of other global companies to replicate this initiative and leverage our new warehouse operations”
    “Our SA strategy is to partner with global healthcare manufacturers in territories where they would prefer to enjoy a partnership rather than set up their own operations in that territory,” Mr Simari said.
    “We run a similar operation in WA very successfully and are looking to achieve the same in SA.
    “This complements our overall strategy of being a national supplier of healthcare products and services across the sector.”
    The company, which posted record revenues of $117.2 million in FY17, expects revenue to come in at between $125 million and $135 million, boosted by acquisitions.
    The group has bought 11 businesses in the past seven years.
    On Wednesday, it announced two new purchases in NSW — Insight Surgical for $5 million and Medtech Solutions for $2.4 million.
    It’s $8.5 million buyout of the Seqirus (CSL) immunohaematology business is in progress and is expected to be settled by March.
    The office will represent Paragon-owned Western Biomedical brands and will provide a full logistics solution. It will also house local representatives for the current Paragon Care brands including Designs for Vision, Paragon Care and a new Service and Technology division.
    Paragon Care has an existing distribution arrangement with Anaequip in SA, which will remain unchanged.
    The South Australian operation will be headed up by Susanne Wilson.
    Paragon Care supplies medical equipment, devices and consumables for the Australian and New Zealand healthcare market.

  4. #14
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado

    Cita Iniciado por jerez1 Ver Mensaje
    Paragon Care ready for SA expansion with new US partner, office facility and warehouse

    Valerina Changarathil, The Advertiser
    December 27, 2017 6:03am


    Subscriber only





    Ads by Kiosked




    VICTORIAN medical equipment supplier Paragon Care has roped in a US partner to expand it distribution footprint in SA.

    Paragon Care will be the exclusive distributor for US medical products supplier Smiths Medical and their suite of products into SA.
    Australian sharemarket-listed Paragon is currently finalising fitout and logistics for a new warehouse and office space in Wingfield, which is due to open next month.
    Managing director Mark Simari said the company was talking to “a number of other global companies to replicate this initiative and leverage our new warehouse operations”
    “Our SA strategy is to partner with global healthcare manufacturers in territories where they would prefer to enjoy a partnership rather than set up their own operations in that territory,” Mr Simari said.
    “We run a similar operation in WA very successfully and are looking to achieve the same in SA.
    “This complements our overall strategy of being a national supplier of healthcare products and services across the sector.”
    The company, which posted record revenues of $117.2 million in FY17, expects revenue to come in at between $125 million and $135 million, boosted by acquisitions.
    The group has bought 11 businesses in the past seven years.
    On Wednesday, it announced two new purchases in NSW — Insight Surgical for $5 million and Medtech Solutions for $2.4 million.
    It’s $8.5 million buyout of the Seqirus (CSL) immunohaematology business is in progress and is expected to be settled by March.
    The office will represent Paragon-owned Western Biomedical brands and will provide a full logistics solution. It will also house local representatives for the current Paragon Care brands including Designs for Vision, Paragon Care and a new Service and Technology division.
    Paragon Care has an existing distribution arrangement with Anaequip in SA, which will remain unchanged.
    The South Australian operation will be headed up by Susanne Wilson.
    Paragon Care supplies medical equipment, devices and consumables for the Australian and New Zealand healthcare market.

    Parece finalizada la corrección,, le veo mucho crecimiento. Van a adquirir otras empresas para seguir creciendo.

    The Paragon Care Ltd (ASX: PGC) share price has fallen by about 10% since the start of 2018, but over the past five years has grown by 152%.
    Paragon is a small cap healthcare business that supplies medical products and equipment like beds to hospitals, aged care facilities and other healthcare locations.
    I believe there are several reasons to like Paragon, here are a few of them:
    Acquisition expansion
    Paragon’s key strategy is to expand the business through acquisitions. A simple roll-up strategy can work out okay, but I think Paragon’s strategy is quite effective.
    It is steadily acquiring businesses that supply different healthcare products with different sets of customers. This means that over time, as Paragon makes more bolt-on acquisitions, it can offer its clients more of their purchasing needs and the new acquisitions may provide Paragon with another set of clients.
    For example, Paragon recently acquired Surgical Specialties Group for $32.4 million. This acquisition is expected to be earnings per share (EPS) accretive in FY18, whilst adding $30 million of annual revenue and $4.9 million of earnings before interest, tax, depreciation and amortisation (EBITDA).
    Customers
    Paragon supplies a variety of different healthcare markets including aged care, hospital & acute care, primary care, eye care, storage solutions, service & technology management, e-health and diagnostics.
    According to the company, before its recent acquisitions, 80% of Paragon’s revenue came from hospitals and 80% of that came from the public system whilst the other 20% came from the private sector.
    With Australia’s clear ageing demographics it’s obvious the growth in total healthcare expenditure will continue to grow and Paragon could benefit from this if it becomes a major supplier for the public sector.
    Underlying growth and dividend
    https://www.fool.com.au/2018/05/08/w...m-opportunity/





  5. #15
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado

    Cita Iniciado por jerez1 Ver Mensaje
    Parece finalizada la corrección,, le veo mucho crecimiento. Van a adquirir otras empresas para seguir creciendo.

    The Paragon Care Ltd (ASX: PGC) share price has fallen by about 10% since the start of 2018, but over the past five years has grown by 152%.
    Paragon is a small cap healthcare business that supplies medical products and equipment like beds to hospitals, aged care facilities and other healthcare locations.
    I believe there are several reasons to like Paragon, here are a few of them:
    Acquisition expansion
    Paragon’s key strategy is to expand the business through acquisitions. A simple roll-up strategy can work out okay, but I think Paragon’s strategy is quite effective.
    It is steadily acquiring businesses that supply different healthcare products with different sets of customers. This means that over time, as Paragon makes more bolt-on acquisitions, it can offer its clients more of their purchasing needs and the new acquisitions may provide Paragon with another set of clients.
    For example, Paragon recently acquired Surgical Specialties Group for $32.4 million. This acquisition is expected to be earnings per share (EPS) accretive in FY18, whilst adding $30 million of annual revenue and $4.9 million of earnings before interest, tax, depreciation and amortisation (EBITDA).
    Customers
    Paragon supplies a variety of different healthcare markets including aged care, hospital & acute care, primary care, eye care, storage solutions, service & technology management, e-health and diagnostics.
    According to the company, before its recent acquisitions, 80% of Paragon’s revenue came from hospitals and 80% of that came from the public system whilst the other 20% came from the private sector.
    With Australia’s clear ageing demographics it’s obvious the growth in total healthcare expenditure will continue to grow and Paragon could benefit from this if it becomes a major supplier for the public sector.
    Underlying growth and dividend
    https://www.fool.com.au/2018/05/08/w...m-opportunity/





    Buen momento, finalizó la corrección y se va a cercando a los máximos del pasado año

  6. #16
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado

    Cita Iniciado por jerez1 Ver Mensaje
    Buen momento, finalizó la corrección y se va a cercando a los máximos del pasado año

    Buen tirón, casi un 4% sube

  7. #17
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado

    Cita Iniciado por jerez1 Ver Mensaje
    Buen tirón, casi un 4% sube

    Rompió la resistencia de 81c, próxima resistencia los 91c

  8. #18
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado

    Cita Iniciado por jerez1 Ver Mensaje
    Rompió la resistencia de 81c, próxima resistencia los 91c

    Fuerte compra

    https://es.investing.com/equities/pa...-ltd-technical

  9. #19
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado

    Cita Iniciado por jerez1 Ver Mensaje

    Paragon Care has a new asset in its sights
    Share
    11:30 06 Jun 2018
    Paragon has been acquiring businesses in the healthcare sector.
    Paragon Care has a new asset in its sights
    The company's shares are in pre-open
    Paragon Care Ltd (ASX:PGC) is back on the acquisition trail, with the ASX granting the company a trading halt this morning pending its next bolt on.

    Earlier in the year Paragon outlined nine acquisition opportunities in the healthcare sector during the company's $69.8 million capital raising.


    Seven of these have been completed so far.

    Paragon is also set for a busy June quarter, as historically over a third of the year’s business has normally been transacted during this period.

    The company is a provider of medical equipment, devices and consumables for the Australian and New Zealand healthcare market.

    The halt will remain in place until the opening of trade on Friday 8 June 2018, or earlier if an announcement is made to the market.



    Share



    Paragon Care Ltd has a new asset in its sights

  10. #20
    Fecha de Ingreso
    junio-2014
    Mensajes
    1.675
    Agradecimiento de Post / Me gusta

    Predeterminado

    Cita Iniciado por jerez1 Ver Mensaje
    Paragon Care has a new asset in its sights
    Share
    11:30 06 Jun 2018
    Paragon has been acquiring businesses in the healthcare sector.
    Paragon Care has a new asset in its sights
    The company's shares are in pre-open
    Paragon Care Ltd (ASX:PGC) is back on the acquisition trail, with the ASX granting the company a trading halt this morning pending its next bolt on.

    Earlier in the year Paragon outlined nine acquisition opportunities in the healthcare sector during the company's $69.8 million capital raising.


    Seven of these have been completed so far.

    Paragon is also set for a busy June quarter, as historically over a third of the year’s business has normally been transacted during this period.

    The company is a provider of medical equipment, devices and consumables for the Australian and New Zealand healthcare market.

    The halt will remain in place until the opening of trade on Friday 8 June 2018, or earlier if an announcement is made to the market.



    Share



    Paragon Care Ltd has a new asset in its sights

    Adquieren Rem Systems, sube un 4%

    Should you buy Paragon Care Ltd. (ASX:PGC) after its acquisition spree?
    Tommaso Autorino | June 8, 2018 | More on: PGC

    Shares in Paragon Care Ltd (ASX: PGC) rose 3% to $0.84c on Friday morning’s trade, after the company announced the acquisition of New Zealand-based healthcare business REM Systems for a net enterprise value of NZ$54 million (about $50 million).
    The details of the transaction
    Paragon will settle 80% of the purchase in cash and the rest through the issuance of 12.7 million shares at the 30-day volume-weighted average price of $0.76c. In addition, the deal includes earn-out provision of 4.5 times FY20 and FY21 incremental EBITDA from the acquisition. REM’s vendors and executive management will stay with the business throughout the earn-out period.
    REM has a forecast FY18 revenue base of NZ$68 million and EBITDA of NZ$7 million.
    Funding for the transaction derives partly from Paragon’s recent $70 million capital raising and partly from an increased debt facility with National Australia Bank (ASX: NAB). Paragon’s net debt to EBITDA ratio is expected to be between 2x and 2.5x following the acquisition.
    Strategic rationale
    Paragon’s Chairman, Shane Tanner, described REM as a “near perfect strategic fit”.
    Through a series of acquisitions of suppliers of the healthcare sector – seven in the last four months –Paragon has grown to become an integrated healthcare equipment and services provider for acute, aged and primary care in Australia and New Zealand.
    The acquisition of REM is particularly significant given the size of the target – in comparison with Paragon’s market capitalisation of $230 million – and the fact that REM itself is a diversified medical distribution company supplying 4,000 customers including acute care hospitals, day surgeries, medical practices and veterinary clinics throughout New Zealand and Australia, with an articulate structure that resembles Paragon’s.
    Despite its strong organic growth – in the range of 6% to 8% per annum over recent years, according to Paragon’s announcement – REM is still a family run business
    The acquisition is anticipated to be in excess of 10% EPS accretive in FY19 and beyond.
    Foolish takeaway
    I’m usually quite wary of growth built on an acquisition spree, but in this case I think the move makes perfect sense, given the homogeneity between Paragon and REM.
    Based on the company’s forecast, the stock trades at just 11x FY18 earnings. With this valuation, I think Paragon is a good option to gain exposure to the healthcare sector, which is poised to grow in coming years as the Australian population ages.
    But there’s another industry ready to take off. Click here to claim your free report.
    7 of 8 People Are Clueless About This Trillion-Dollar Market
    One of our investors has recently returned from a research trip to Silicon Valley... and has a warning for fellow investors:
    Because he works for an organization dedicated to spreading great investing ideas, his video report is free today... so you can see it and decide for yourself.
    Don't miss your chance click here to learn about this warning and how you might be able to profit!
    Motley Fool contributor Tommaso Autorino has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of National Australia Bank Limited. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.















Marcadores

Normas de Publicación

  • No puedes crear nuevos temas
  • No puedes responder temas
  • No puedes subir archivos adjuntos
  • No puedes editar tus mensajes
  •